Skip to main content

Table 1 Baseline characteristics of study population

From: Study of T Cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART

 

Effective Group

Ineffective Group

Untreated Group

Control Group

Number of Subjects

25

18

17

15

Sex

    

   Male

19(76%)

13(72.2%)

13(76.5%)

9(60%)

   Female

6(24%)

5(27.8%)

4(23.5%)

6(40%)

Age

47.6 ± 9.1

45.7 ± 10.4

39.7 ± 11.3

40.5 ± 9.7

 

(35~71)

(31~60)

(36~63)

(33~57)

Transmission

    

   Sexual

21(84%)

16(88.8%)

16(94.1%)

--

   Blood

3(12%)

1(5.6%)

1(5.9%)

--

   Other

1(4%)

1(5.6%)

0

--

CD4+ T (cells/[μL) *

187

175

341

736

 

(22~367)

(56~341)

(78~400)

(452~1038)

   < 200

13(52%)

10(55.6%)

2(11.8%)

0

   ≥ 200~ < 350

11(44%)

8(44.4%)

5(29.4%)

0

   ≥ 350

1(4%)

0

10(58.8%)

15(100%)

Therapy

    

   2NRTIs+NNRTI

13(52%)

11(61.1%)

--

--

   2NRTIs+PI

12(48%)

7(38.9%)

--

--

  1. *: baseline CD4+ T cell counts are shown by medians with ranges. NRTI: Nucleoside Reverse Transcriptase Inhibitor, NNRTI: Non-nucleoside Reverse Transcriptase Inhibitor, PI: Protease Inhibitor.